세계의 마이크로플루이딕스 시장 : 예측(2025-2030년)

The Global Microfluidics Market is expected to grow from USD 33.690 billion in 2025 to USD 47.696 billion in 2030, at a CAGR of 7.20%.

The global microfluidics market is projected to experience robust growth from 2025 to 2030, driven by the increasing demand for point-of-care (POC) diagnostics, advancements in lab-on-a-chip technologies, and the rising need for high-throughput screening in healthcare. Microfluidics, enabling precise manipulation of low-volume samples, is critical for developing portable, efficient diagnostic devices used in applications like cancer detection and infectious disease testing. The market is propelled by technological innovations and growing healthcare expenditures, particularly in the United States. Challenges include high development costs and regulatory hurdles.

Market Drivers

Rising Demand for Point-of-Care (POC) Devices

The increasing adoption of POC diagnostics, particularly in healthcare, is a primary driver of the microfluidics market. These devices, leveraging microfluidic technology, enable rapid, portable testing for conditions like SARS-CoV-2, glucose levels, and cardiac markers, enhancing accessibility and efficiency. For instance, widespread use of POC tests, such as urine dipstick and troponin assays, relies on microfluidic platforms for accurate, low-volume sample analysis. The demand for decentralized testing in clinics and home settings is boosting the market, as microfluidics supports miniaturization and affordability.

Advancements in Diagnostic Technologies

Innovations in microfluidics, such as lab-on-a-chip systems, are driving market growth by enabling rapid and precise diagnostics. In July 2023, Thermo Fisher Scientific launched Diomni Enterprise Software, streamlining molecular testing and enhancing lab efficiency. Such advancements improve diagnostic accuracy and adaptability, supporting applications like cancer detection, where microfluidics enables early-stage analysis and personalized treatment. The rising incidence of cancer in the United States underscores the need for these technologies, further fueling market expansion.

Growing Healthcare Expenditure

Increasing healthcare spending, particularly in the United States, is supporting the adoption of microfluidics in advanced diagnostics. The U.S. healthcare industry's substantial investment in innovative solutions drives demand for microfluidic-based POC devices that improve patient outcomes and reduce costs. The focus on precision diagnostics for chronic diseases and the integration of microfluidics in high-throughput screening are key factors enhancing market growth in this region.

Market Restraints

The microfluidics market faces challenges due to high development and manufacturing costs, which can limit adoption in cost-sensitive regions or applications. Regulatory complexities, including stringent standards for medical device approval, pose barriers to market entry. Additionally, the need for specialized expertise to design and operate microfluidic systems may hinder growth in emerging markets. Addressing these challenges through cost-effective production and streamlined regulatory processes will be critical for sustained expansion.

Market Segmentation

By Application

The market is segmented into POC diagnostics, in vitro diagnostics (IVD), high-throughput screening, and others. POC diagnostics dominate due to their widespread use in healthcare for rapid testing. IVD and high-throughput screening are growing segments, driven by demand for precision diagnostics and drug development.

By Technology

The market includes lab-on-a-chip, microfluidic cartridges, and others. Lab-on-a-chip leads due to its versatility in diagnostics, while microfluidic cartridges are critical for POC applications.

By Geography

The market is segmented into North America, Asia-Pacific, Europe, South America, and the Middle East and Africa. North America, led by the United States, holds a significant share due to its large healthcare market and focus on advanced diagnostics. Asia-Pacific is expected to grow rapidly, driven by increasing healthcare investments and industrialization in countries like China and India. Europe, South America, and the Middle East and Africa are emerging markets with growing potential.

The microfluidics market is set for robust growth from 2025 to 2030, driven by demand for POC diagnostics, advancements in lab-on-a-chip technologies, and rising healthcare expenditures. Innovations like Thermo Fisher's Diomni Enterprise Software, launched in July 2023, highlight the market's transformative potential. Despite challenges like high costs and regulatory hurdles, the outlook is positive, particularly in North America and Asia-Pacific. Industry players must focus on cost-effective, scalable solutions to capitalize on the growing demand for microfluidics in precision diagnostics and healthcare applications.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2020 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Component

• Chips
• Pumps
• Sensors
• Others

By Sector

• Industrial
• Healthcare

By Application

• Point-of-care (POC) Diagnostics
• Drug Delivery Systems
• In-Vitro Diagnostics (IVD)
• Pharmaceutical and Life Sciences Research

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• Japan
• India
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL MICROFLUIDS MARKET BY COMPONENT

• 5.1. Introduction
• 5.2. Chips
• 5.3. Pumps
• 5.4. Sensors
• 5.5. Others

6. GLOBAL MICROFLUIDS MARKET BY SECTOR

• 6.1. Introduction
• 6.2. Industrial
• 6.3. Healthcare

7. GLOBAL MICROFLUIDS MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Point-of-care (POC) Diagnostics
• 7.3. Drug Delivery Systems
• 7.4. In-Vitro Diagnostics (IVD)
• 7.5. Pharmaceutical and Life Sciences Research

8. GLOBAL MICROFLUIDS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Illumina, Inc.
• 10.2. F. Hoffman-La Roche Ltd
• 10.3. PerkinElmer, Inc
• 10.4. Agilent Technologies, Inc
• 10.5. Bio-Rad Laboratories, Inc
• 10.6. Abbott
• 10.7. Standard BioTools
• 10.8. Agilent Technologies
• 10.9. Thermo Fisher Scientific
• 10.10. Danaher Corporation

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations